SCHEMBL6897130

SCHEMBL6897130

CCCC(O)/C=C/c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP1A2 P05177 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NPC1 O15118 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
AOC3 Q16853 1/20 0.40
CNR2 P34972 1/20 0.39
HTR2A P28223 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6897132 1.00 MEN1 (0.42) MEN1KMT2ACYP3A4CYP1A2HDAC3
SCHEMBL160811 0.87 TRPA1 (0.47) HDAC3TDP1
SCHEMBL301113 0.87 TRPA1 (0.47) HDAC3TDP1
SCHEMBL27642615 0.86 EGFR (0.47) TDP1
SCHEMBL866662 0.84 MEN1 (0.49) MEN1KMT2ACYP3A4CYP1A2NPC1
SCHEMBL2522305 0.84 MEN1 (0.49) MEN1KMT2ACYP3A4CYP1A2NPC1
SCHEMBL866661 0.84 MEN1 (0.49) MEN1KMT2ACYP3A4CYP1A2NPC1
SCHEMBL11960056 0.84 MEN1 (0.49) MEN1KMT2ACYP3A4CYP1A2NPC1
SCHEMBL11959996 0.84 MEN1 (0.49) MEN1KMT2ACYP3A4CYP1A2NPC1
SCHEMBL11530802 0.81 HRH1 (0.42) CYP3A4CYP1A2CNR2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10391182-B2 Bifunctional cytotoxic agents PFIZER INC. (US) 2019-08-27 US disclosed
EP-0861858-B1 Polymeric surface coatings BIOCOMPATIBLES UK LTD (GB) 2004-06-30 EP disclosed
US-6395800-B1 BLEND OF 2-(METHACRYLOYLOXYETHYL)-2*-(TRIMETHYLAMMONIUM)ETHYL PHOSPHATE POLYMER; MEDICAL EQUIPMENT, CATHETERS; BIOCOMPATIBILITY BIOCOMPATIBLES LIMITED (GB) 2002-05-28 US disclosed
US-6225431-B1 COATING SURFACE OF MEDICAL DEVICE WITH POLYMER FORMED BY RADICAL POLYMERIZATION OF ETHYLENICALLY UNSATURATED MONOMERS DISPERSED OR DISSOLVED IN A SOLVENT AND THE SOLVENT IS REMOVED TO LEAVE A STABLE COATING ON SURFACE BIOCOMPATIBLES LIMITED 2001-05-01 US disclosed
US-6150432-A IMPROVING THE BIOCOMPATIBILITY OF A POLYMER, DISPERSION OF A POLYMER AND INCREASE LUBRICITY BY BLENDING WITH A ZWITTERIONIC POLYMER; A MEDICAL EQUIPMENT WITH REDUCING FIBRINOGEN ABSORPTION, PLATELET ACTIVATION BIOCOMPATIBLES LIMITED (GB) 2000-11-21 US disclosed
EP-0810239-B1 Polymeric surface coatings BIOCOMPATIBLES LTD (GB) 2000-09-20 EP disclosed
EP-0818479-B1 Polymeric surface coatings BIOCOMPATIBLES LTD (GB) 2000-09-13 EP disclosed
US-6087462-A BONDING OF COATINGS TO SURFACES WITH ZWITTWRIONS BIOCOMPATIBLES LIMITED (GB) 2000-07-11 US disclosed
EP-0593561-B1 POLYMERIC SURFACE COATINGS BIOCOMPATIBLES LTD (GB) 2000-03-22 EP disclosed
EP-0626983-B1 POLYMERIC BLENDS WITH ZWITTERIONIC GROUPS BIOCOMPATIBLES LTD (GB) 1999-04-14 EP disclosed
US-5705583-A RENDERING SURFACES BIOCOMPATIBLE BIOCOMPATIBLES LIMITED (GB) 1998-01-06 US disclosed
EP-0810239-A2 Polymeric surface coatings BIOCOMPATIBLES LIMITED (GB) 1997-12-03 EP disclosed
US-5648442-A ZWITTERIONIC POLYMERS BIOCOMPATIBLES LIMITED (GB) 1997-07-15 US disclosed
US-5453467-A Polymers grafted with quaternary ammonium phosphate acrylates1 BIOCOMPATIBLES LIMITED (GB) 1995-09-26 US disclosed
EP-0626983-A1 POLYMERIC BLENDS WITH ZWITTERIONIC GROUPS BIOCOMPATIBLES LIMITED (GB) 1994-12-07 EP disclosed
WO-1994014897-A1 POLYMERIC BLENDS WITH ZWITTERIONIC GROUPS BIOCOMPATIBLES LIMITED (GB) 1994-07-07 WO disclosed
EP-0601041-A1 POLYMER TREATMENTS BIOCOMPATIBLES LIMITED (GB) 1994-06-15 EP disclosed
EP-0593561-A1 POLYMERIC SURFACE COATINGS BIOCOMPATIBLES LIMITED (GB) 1994-04-27 EP disclosed
WO-1993005081-A1 POLYMER TREATMENTS BIOCOMPATIBLES LTD. (GB) 1993-03-18 WO disclosed
WO-1993001221-A1 POLYMERIC SURFACE COATINGS BIOCOMPATIBLES LIMITED (GB) 1993-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10391182-B2 Bifunctional cytotoxic agents PAICS, CYTH3, CYTH2 MEN1 3380/4885KMT2A 2521/4885CYP3A4 4046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.